2014 Clinical Investigator Award Recipients



Ryan C. Fields, MD
Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine
Identifying Novel Mechanisms of Metastases in Colorectal Cancer
Supported by an educational grant from Genentech



 Ryan C. Fields, M.D., F.A.C.S. is an Assistant Professor of Hepato-pancreato-biliary, Gastrointestinal, and Oncologic Surgery at Barnes-Jewish Hospital and the Alvin J. Siteman Cancer Center at Washington University School of Medicine in St. Louis, Missouri. He also serves as an Associate Program Director for the General Surgery Residency Program and is Director of Resident Research. Dr. Fields completed his undergraduate studies at the University of Michigan where he was mentored in Cancer Immunology and Biology by Drs. Alfred Chang, Vernon Sondak, and James Mulé. He received his MD degree from Duke University where he was mentored by Dr. Douglas Tyler and completed a General Surgery Residency at Barnes-Jewish Hospital at Washington University School of Medicine in St. Louis, where he worked with Drs. Timothy Eberlein, David Linehan, William Hawkins, and Jeffrey Moley. After completing a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center under the leadership of Drs. Murray Brennan and Ronald DeMatteo, Dr. Fields joined the faculty at Washington University. His clinical interests include the treatment of primary and secondary/metastatic liver tumors, pancreatic cancer, gastric cancer, sarcoma, and melanoma/skin cancer. His research focuses on the biology and genetics of cancer metastases. Through collaborations at The Genome Institute at Washington University and the Department of Medical Oncology, Dr. Fields and his team are applying cutting edge genomic techniques to investigate the changes a tumor undergoes from primary malignancy to metastatic disease.



Stephen Grobmyer, MD
Cleveland Clinic
The Microbiome and Human Breast Cancer
Supported by an educational grant from Amgen




 Dr. Stephen Grobmyer completed his fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center in 2004. Formerly, the Edward M. Copeland III Chair in Surgical Oncology Research at University of Florida; he is now Section Head of Surgical Oncology and Director of the Breast Center at Cleveland Clinic in Cleveland, Ohio. His externally focused cancer research program has focused on application of novel nanomaterials for cancer prevention, diagnosis and treatment. Nationally, he serves on the American Society of Clinical Oncology Breast Cancer Education Committee, and he recently completed his term as scientific program committee chair for the Society of Surgical Oncology. He serves on the breast cancer advisory committee for the American Board of Surgery and serves on the editorial board of The European Journal of Surgical Oncology, The Annals of Surgical Oncology, and The Breast Journal.